Related Articles
A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus
Cardioprotective effects of exenatide against oxidative stress-induced injury
Liraglutide protects palmitate-induced INS-1 cell injury by enhancing autophagy mediated via FoxO1
Combination of peroxisome proliferator-activated receptor α/γ agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion
Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19